Radiation Toxicity - Drugs In Development, 2021

July 2021 | 337 pages | ID: R0CBF0FDDF20EN
Global Markets Direct

Abstracts

Radiation Toxicity - Drugs In Development, 2021

SUMMARY

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Drugs In Development, 2021, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline landscape.Radiation Toxicity (also known as radiation sickness) is an acute illness caused by irradiation of the entire body by a high dose of penetrating radiation in a very short period of time (usually a matter of minutes). The major cause of this syndrome is depletion of immature parenchymal stem cells in specific tissues. Symptoms include bleeding from the nose, mouth, gums, and rectum, bloody stool, bruising, confusion, dehydration, diarrhea, fainting and fatigue.

REPORT HIGHLIGHTS

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 2, 12, 8, 1, 50, 9 and 1 respectively. Similarly, the Universities portfolio in Preclinical, Discovery and Unknown stages comprises 6, 1 and 1 molecules, respectively.Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

SCOPE

• The pipeline guide provides a snapshot of the global therapeutic landscape of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology).%li%The pipeline guide reviews pipeline therapeutics for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.%li%The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.%li%The pipeline guide reviews key companies involved in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) therapeutics and enlists all their major and minor projects.%li%The pipeline guide evaluates Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.%li%The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology)

REASONS TO BUY

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.%li%Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.%li%Find and recognize significant and varied types of therapeutics under development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology).%li%Classify potential new clients or partners in the target demographic.%li%Develop tactical initiatives by understanding the focus areas of leading companies.%li%Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.%li%Formulate corrective measures for pipeline projects by understanding Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline depth and focus of Indication therapeutics.%li%Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.%li%Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contents

Introduction
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Overview
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Therapeutics Development
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Therapeutics Assessment
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Companies Involved in Therapeutics Development
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Drug Profiles
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Discontinued Products
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Product Development Milestones
Appendix

List Of Tables

LIST OF TABLES

Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by 21st Century Therapeutics Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by 9 Meters Biopharma Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Advanced Innovative Partners Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Advenchen Laboratories LLC, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Allander Biotechnologies LLC, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Amryt Pharma Plc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Angion Biomedica Corp, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Aqualung Therapeutics Corp, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Atox Bio Ltd, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by BCN Biosciences LLC, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by BioCurity Pharmaceuticals Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by BioIncept LLC, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Bolder Biotechnology Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Cellphire Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Ceramedix Holding LLC, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Ceramide Therapeutics LLC, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Chrysalis BioTherapeutics Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Cleveland BioLabs Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Clevexel Pharma SA, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Connext Co Ltd, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Consegna Pharma Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Creative Medical Technology Holdings Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Eagle Pharmaceuticals Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Enveric Biosciences Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Enzychem Lifesciences Corp, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by EpicentRx Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Exponential Biotherapies Inc, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Dormant Projects, 2021
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Discontinued Products, 2021

List Of Figures

LIST OF FIGURES

Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021